324 related articles for article (PubMed ID: 28165915)
21. Antibody humanization by framework shuffling.
Dall'Acqua WF; Damschroder MM; Zhang J; Woods RM; Widjaja L; Yu J; Wu H
Methods; 2005 May; 36(1):43-60. PubMed ID: 15848074
[TBL] [Abstract][Full Text] [Related]
22. Humanized antibody neutralizing 2009 pandemic H1N1 virus.
Shembekar N; Mallajosyula VV; Chaudhary P; Upadhyay V; Varadarajan R; Gupta SK
Biotechnol J; 2014 Dec; 9(12):1594-603. PubMed ID: 25044602
[TBL] [Abstract][Full Text] [Related]
23. Use of IMGT
Lefranc MP; Ehrenmann F; Kossida S; Giudicelli V; Duroux P
Methods Mol Biol; 2018; 1827():35-69. PubMed ID: 30196491
[TBL] [Abstract][Full Text] [Related]
24. SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity.
Gonzales NR; Padlan EA; De Pascalis R; Schuck P; Schlom J; Kashmiri SV
Mol Immunol; 2004 Jul; 41(9):863-72. PubMed ID: 15261458
[TBL] [Abstract][Full Text] [Related]
25. Matrixed CDR grafting: A neoclassical framework for antibody humanization and developability.
Gupta P; Horspool AM; Trivedi G; Moretti G; Datar A; Huang ZF; Chiecko J; Kenny CH; Marlow MS
J Biol Chem; 2024 Jan; 300(1):105555. PubMed ID: 38072062
[TBL] [Abstract][Full Text] [Related]
26. Antibody humanization methods for development of therapeutic applications.
Ahmadzadeh V; Farajnia S; Feizi MA; Nejad RA
Monoclon Antib Immunodiagn Immunother; 2014 Apr; 33(2):67-73. PubMed ID: 24746146
[TBL] [Abstract][Full Text] [Related]
27. Paratome: an online tool for systematic identification of antigen-binding regions in antibodies based on sequence or structure.
Kunik V; Ashkenazi S; Ofran Y
Nucleic Acids Res; 2012 Jul; 40(Web Server issue):W521-4. PubMed ID: 22675071
[TBL] [Abstract][Full Text] [Related]
28. A germline knowledge based computational approach for determining antibody complementarity determining regions.
Zhao S; Lu J
Mol Immunol; 2010 Jan; 47(4):694-700. PubMed ID: 19939452
[TBL] [Abstract][Full Text] [Related]
29. Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications.
Goydel RS; Weber J; Peng H; Qi J; Soden J; Freeth J; Park H; Rader C
J Biol Chem; 2020 May; 295(18):5995-6006. PubMed ID: 32193207
[TBL] [Abstract][Full Text] [Related]
30. Antibody humanization-the Influence of the antibody framework on the CDR-H3 loop ensemble in solution.
Fernández-Quintero ML; Heiss MC; Liedl KR
Protein Eng Des Sel; 2019 Dec; 32(9):411-422. PubMed ID: 32129452
[TBL] [Abstract][Full Text] [Related]
31. Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies.
Townsend S; Fennell BJ; Apgar JR; Lambert M; McDonnell B; Grant J; Wade J; Franklin E; Foy N; Ní Shúilleabháin D; Fields C; Darmanin-Sheehan A; King A; Paulsen JE; Hickling TP; Tchistiakova L; Cunningham O; Finlay WJ
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15354-9. PubMed ID: 26621728
[TBL] [Abstract][Full Text] [Related]
32. Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31.
Kim WT; Shin S; Hwang HJ; Kim MK; Jung HS; Park H; Ryu CJ
PLoS One; 2016; 11(12):e0167527. PubMed ID: 27907150
[TBL] [Abstract][Full Text] [Related]
33. New high affinity monoclonal antibodies recognize non-overlapping epitopes on mesothelin for monitoring and treating mesothelioma.
Zhang YF; Phung Y; Gao W; Kawa S; Hassan R; Pastan I; Ho M
Sci Rep; 2015 May; 5():9928. PubMed ID: 25996440
[TBL] [Abstract][Full Text] [Related]
34. Design, expression and characterization of a single chain anti-CD20 antibody; a germline humanized antibody derived from Rituximab.
Ahmadzadeh V; Farajnia S; Hosseinpour Feizi MA; Khavarinejad RA
Protein Expr Purif; 2014 Oct; 102():45-51. PubMed ID: 25088934
[TBL] [Abstract][Full Text] [Related]
35. Atypical antigen recognition mode of a shark immunoglobulin new antigen receptor (IgNAR) variable domain characterized by humanization and structural analysis.
Kovalenko OV; Olland A; Piché-Nicholas N; Godbole A; King D; Svenson K; Calabro V; Müller MR; Barelle CJ; Somers W; Gill DS; Mosyak L; Tchistiakova L
J Biol Chem; 2013 Jun; 288(24):17408-19. PubMed ID: 23632026
[TBL] [Abstract][Full Text] [Related]
36. Humanization of antibodies using heavy chain complementarity-determining region 3 grafting coupled with in vitro somatic hypermutation.
Bowers PM; Neben TY; Tomlinson GL; Dalton JL; Altobell L; Zhang X; Macomber JL; Wu BF; Toobian RM; McConnell AD; Verdino P; Chau B; Horlick RA; King DJ
J Biol Chem; 2013 Mar; 288(11):7688-7696. PubMed ID: 23355464
[TBL] [Abstract][Full Text] [Related]
37. Use of IMGT(®) databases and tools for antibody engineering and humanization.
Lefranc MP; Ehrenmann F; Ginestoux C; Giudicelli V; Duroux P
Methods Mol Biol; 2012; 907():3-37. PubMed ID: 22907343
[TBL] [Abstract][Full Text] [Related]
38. Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform.
Gjetting T; Gad M; Fröhlich C; Lindsted T; Melander MC; Bhatia VK; Grandal MM; Dietrich N; Uhlenbrock F; Galler GR; Strandh M; Lantto J; Bouquin T; Horak ID; Kragh M; Pedersen MW; Koefoed K
MAbs; 2019; 11(4):666-680. PubMed ID: 31046547
[TBL] [Abstract][Full Text] [Related]
39. A two-in-one antibody engineered from a humanized interleukin 4 antibody through mutation in heavy chain complementarity-determining regions.
Lee CV; Koenig P; Fuh G
MAbs; 2014; 6(3):622-7. PubMed ID: 24618680
[TBL] [Abstract][Full Text] [Related]
40. RosettaAntibodyDesign (RAbD): A general framework for computational antibody design.
Adolf-Bryfogle J; Kalyuzhniy O; Kubitz M; Weitzner BD; Hu X; Adachi Y; Schief WR; Dunbrack RL
PLoS Comput Biol; 2018 Apr; 14(4):e1006112. PubMed ID: 29702641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
